Wall Street retreats ahead of BigTech reports pressured by Meta results and GDP 📉
Declines on Wall Street are accelerating after today's release of Q1 2024 GDP data. The annualized change in GDP was just 1.6%, against a forecast of 2.5%. For stock market investors, however, a worse sign is the news of persistently high inflation. The GDP deflator rose to 3.1% from 1.7% at the end of last year, while the PCE Core rebounds to 3.7% from 2.0%, much above expectations. This is the worst mix of all possibles: an economic slowdown and persistently high inflation (higher than GDP = stagflation). In view of this, we are seeing a sharp decline in the valuation of interest rate cuts in the US. The probability for September is 40%, while the cumulative probability is less than 75%. The first reduction (and not all of it!) is priced for November, with December priced with almost 100% probability.
The US reduction is getting further and further away.... Source: Bloomberg Finance LP
Start investing today or test a free demo
Open real account TRY DEMO Download mobile app Download mobile appIn addition to this, it is worth noting the massive declines of Meta, which are related to weak forward guidance, despite high spending on AI. Technology giants such as Microsoft (-3.7%) and Alphabet (-2.8%) are also losing ahead of today's earnings release. We wrote about Meta and today's publishers earlier.
Many key technology companies are losing today. Source: Bloomberg Finance LP
The US100 is losing nearly 1% today, while the Nasdaq cash index is losing as much as 1.6%, which is of course linked to losses by Meta and other tech related companies. The US100 is reducing more than half of its recent rebound, and there are plenty of indications that there may be a renewed attempt to descend near 17,000 points. Slightly below is the retracement of 38.2 of the last Fibonacci upward wave and the extent of a major correction in the uptrend that has lasted since the fall of 2022.
Source: xStation5
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.